Related Experiment Video
Updated: May 11, 2026
04:56
Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
SFTPC mutations cause SP-C degradation and aggregate formation without increasing ER stress
Tobias Thurm1, Eva Kaltenborn, Sunčana Kern
1Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University, Munich, Germany.
European Journal of Clinical Investigation
|May 25, 2013
Summary
Mutations in surfactant protein C (SP-C) cause interstitial lung disease (ILD). Different SP-C mutations lead to unique cellular defects, requiring individualized therapies for effective treatment.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Genetics
Background:
- Mutations in the surfactant protein C (SP-C) gene are linked to familial and sporadic interstitial lung disease (ILD).
- Current therapeutic strategies for ILD are limited due to insufficient understanding of disease mechanisms.
- Investigating the cellular fate of mutant SP-C proprotein (proSP-C) is essential for developing targeted therapies.
Purpose of the Study:
- To investigate the cellular consequences of various SP-C mutations found in ILD patients.
- To identify potential therapeutic targets by understanding proSP-C trafficking and aggregation.
Main Methods:
- Stable transfection of A549 alveolar epithelial cells with different proSP-C mutations.
- Analysis of mutant proSP-C using Western blotting, immunofluorescence, and Congo red staining.
Main Results:
- Certain SP-C mutations (p.I73T, p.L110R, p.A116D, p.L188Q) caused aberrant proSP-C trafficking to lamellar bodies.
- Other mutations (p.P30L, p.P115L) resulted in endoplasmic reticulum (ER) retention.
- Most mutations led to intracellular aggregation of Congo red-positive material, without inducing ER stress.
Conclusions:
- SP-C mutations exhibit distinct effects on alveolar epithelial cell biology.
- The impact of SP-C mutations cannot be predicted solely by their location.
- Detailed study of individual SP-C mutations is crucial for developing personalized ILD therapies.
Related Concept Videos
01:02Long-patch Base Excision Repair
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
01:37The Unfolded Protein Response
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...